HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beraprost sodium protects against chronic brain injury in aluminum-overload rats.

AbstractBACKGROUND:
Aluminum overload can cause severe brain injury and neurodegeneration. Previous studies suggest that prostacyclin synthase (PGIS) expression and prostacyclin receptor (IP) activation are beneficial for treatment of acute traumatic and ischemic brain injury. However, the potential value of PGIS/IP signaling pathway to chronic brain injury is still unclear. In this study, we investigated the change of PGIS/IP signaling pathway and the effect of beraprost sodium (BPS) on chronic brain injury in chronic aluminum-overload rats.
METHODS:
Rat model of chronic cerebral injury was established by chronic intragastric administration of aluminum gluconate(Al3+ 200 mg/kg per day,5d a week for 20 weeks). The methods of ELISA, qRT-PCR and Western blotting were used to detect the PGI2 level and the PGIS and IP mRNA and protein levels in hippocampi of chronic aluminum-overload rats, respectively. Rat hippocampal superoxide dismutase (SOD) activity and malondialdehyde (MDA) content also were measured. The effects of BPS (6, 12 and 24 μg⋅kg(-1)) on brain injury in chronic aluminum-overload rats were evaluated.
RESULTS:
Compared with the control group, PGIS mRNA expression, PGI2 level, and the IP mRNA and protein expressions significantly increased in hippocampi of chronic aluminum-overload rats. Administration of BPS significantly improved spatial learning and memory function impairment and hippocampal neuron injury induced by chronic aluminum overload in rats. Meanwhile, administration of BPS resulted in a decrease of PGI2 level and downregulation of PGIS and IP expressions in a dose-dependent manner. Aluminum overload also caused a decrease of SOD activity and an increase of MDA content. Administration of BPS significantly blunted the decrease of SOD activity and the increase of MDA content induced by aluminum overload in rats.
CONCLUSIONS:
BPS has a significant neuroprotective effect on chronic brain injury induced by aluminum overload in rats. Remodeling the balance of PGIS/IP signaling pathway and inhibition of oxidative stress involve in the neuroprotective mechanism of BPS in aluminum-overload rats. The PGIS/IP signaling pathway is a potential therapeutic strategy for chronic brain injury patients.
AuthorsYongquan Pan, Lijuan Yu, Wenjuan Lei, Yuanxin Guo, Jianfeng Wang, Huarong Yu, Yong Tang, Junqing Yang
JournalBehavioral and brain functions : BBF (Behav Brain Funct) Vol. 11 Pg. 6 (Feb 07 2015) ISSN: 1744-9081 [Electronic] England
PMID25888780 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aluminum Compounds
  • Anti-Inflammatory Agents, Non-Steroidal
  • Gluconates
  • Nerve Tissue Proteins
  • Neuroprotective Agents
  • Receptors, Epoprostenol
  • beraprost
  • Malondialdehyde
  • Cytochrome P-450 Enzyme System
  • Aluminum
  • Epoprostenol
  • Superoxide Dismutase
  • Intramolecular Oxidoreductases
  • prostacyclin synthetase
Topics
  • Aluminum (metabolism)
  • Aluminum Compounds
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Brain Damage, Chronic (chemically induced, prevention & control)
  • Cytochrome P-450 Enzyme System (metabolism)
  • Epoprostenol (analogs & derivatives, biosynthesis, therapeutic use)
  • Gluconates
  • Hippocampus (metabolism, pathology)
  • Intramolecular Oxidoreductases (metabolism)
  • Male
  • Malondialdehyde (metabolism)
  • Maze Learning (drug effects)
  • Memory Disorders (chemically induced, prevention & control, psychology)
  • Nerve Tissue Proteins (biosynthesis)
  • Neuroprotective Agents (therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Epoprostenol (drug effects)
  • Superoxide Dismutase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: